Unapproved prescriptions in two pediatric intensive care units in Israel

Vladimir Gavrilov1, Matityahu Berkovitch2, Galina Ling1

  • 1Department of Pediatrics, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

Pediatric intensive care units (PICUs) in Israel frequently use unapproved medications, with over 80% of patients receiving them. This highlights an urgent need to study these off-label and unlicensed drug uses in children.

Area of Science:

  • Pediatric intensive care
  • Pharmacology
  • Drug safety

Background:

  • Many medications used in children lack FDA approval due to insufficient clinical trials.
  • Unapproved drug use in pediatric populations increases the risk of adverse drug reactions.

Purpose of the Study:

  • To evaluate the prevalence of unapproved (off-label and/or unlicensed) medication use in Israeli pediatric intensive care units (PICUs).

Main Methods:

  • Retrospective and prospective analysis of medications administered to patients in two PICUs in Israel.
  • Inclusion of 158 patient records from Soroka University Medical Center and Assaf Harofe Medical Center.

Main Results:

  • Over 80% of patients received unapproved medications, with similar rates in both PICUs.
  • Commonly unapproved drug classes included sympathomimetics, sedatives, antibiotics, anti-infectives, antiasthmatics, and acetaminophen.
  • Inappropriate age was the most frequent reason for off-label prescribing, followed by dose, indication, and route.

Conclusions:

  • A high incidence of unapproved medication prescriptions was observed in Israeli PICUs.
  • There is an urgent need for further investigation into the use of these medications in pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
401
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
548
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
955
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116